FOLH1 and neoplasm: However, when PSA concentrations first begin to rise ( < 0.5 ng/ml), detection depends on the histologically-confirmed tumor size and expression of radiotracer target (e.g., prostate-specific membrane antigen [PSMA]), which can be suboptimal, resulting in limited sensitivity [22, 25–27].